Fluence recognizes the imperative for ethical, standardized, and compliant training in psychedelic clinical trials to ensure patient safety and rigorous research. Our clinical research consultation and training services are designed, overseen, and provided by licensed clinicians with experience on the world’s most advanced psychedelic clinical treatment trials.
And, we’ve worked with a dozen drug developers and multiple compounds in multilingual and multinational contexts, demonstrating capacity and experience delivering rigorous clinical trial training at scale.
Custom Learning Management System
Secure, role-based access to training materials for trainees, sponsors, and CROs.
Mobile App
For your learning platform to promote ease of access to materials and support completion for busy trainees.
Content Library
Featuring training and education for the fundamentals of psychedelic therapy, adverse events, ethics, specific molecules, and demonstration sessions that reduces production cost and time.
Differentiated Training Programs and Tracks
For study clinicians, site staff, sponsor staff, and others as needed.
Timestamped Training Tracking & Documentation
Of training completion.
Custom demonstration and didactic videos filmed by professional videographers in collaboration with experienced clinicians.
Custom
assessments
Live-in-person training sessions
Live-online training sessions
Feedback sessions
Competency evaluations
Peer Mentoring
Our peer mentoring model engages and supports experienced study clinicians to lead supportive group mentoring sessions throughout the duration of your study.
Educational Consultation
Effective oversight ensures that study clinicians have a designated support system in place for ongoing development and remediation as needed. Our experienced research therapists provide consultation in a structured, documented manner aligned to study protocols that support fidelity and patient safety.
Educational Consultation services can be delivered in coordination with mpathic when sponsors leverage mpathic’s technology to analyze therapist adherence during active clinical trials, using HIPAA-compliant, validated AI to provide detailed insights into therapist performance. Fluence’s educational consultants then use these insights to tailor their feedback and guidance. This complementary approach enables Fluence to concentrate on training and skills development, while mpathic provides essential conversation analytics, empowers drug developers to enhance therapist effectiveness and reliability throughout active trial stages, establishing new standards for psychedelic clinical trials.
Fluence Educational Consultation services are also available as a stand-alone service without AI support.
Reference:
PRWeb
Reduce costs and training timelines with AI supported Trainee Feedback
Fluence is at the forefront of innovation—leveraging generative AI to provide actionable feedback tailored to clinical staff needs that improves efficiency, relevance, and efficiency for our drug development partners.
Automated feedback
The AI tool evaluates provider-patient interactions according to a customized rubric to identify areas for improvement quickly and reliably.
Identify opportunities
If a provider misses a given adherence criteria the AI analysis will highlight this in a detailed report.
Increased efficiency of live trainer sessions
Fluence trainers conducting live feedback and assessment sessions can focus on key areas of improvement and competency development with greater efficiency.
This innovative AI tool is being integrated into Fluence’s training programs for healthcare providers involved in clinical trials with leading partners like Reunion Neuroscience and Cybin.
Scalable training
The tool supports therapist development at scale–a critical factor for the future of psychedelic treatments post-approval.
Cost savings and efficiency
Automated feedback allows drug development partners to reduce costs and streamline training without sacrificing rigor and reliability.
Real-world impact
These innovations ensure providers are better prepared to deliver effective psychedelic therapy, improving patient outcomes in clinical trials and beyond.
Innovations in facilitator learning and development are crucial for scalability of psychedelic treatments post-approval, Fluence is demonstrating excellent leadership in exploring and integrating technology-based competency development and assessment tools.
Alex Kelman,
Ph.D., Head of Therapies at Cybin
At Reunion Neuroscience, we are committed to advancing innovative treatments for mental health conditions. Our partnership with Fluence … exemplifies our dedication to leveraging cutting-edge technologies to enhance the quality and scalability of psychedelic therapy. We believe this AI-powered training tool will not only benefit our clinical trials but also contribute to the broader field of psychedelic-assisted therapy, ultimately improving patient outcomes.
Greg Mayes,
CEO of Reunion Neuroscience
Read more about our enterprise solutions:
For more information about Fluence’s innovative training programs and partnerships, contact us.
